[HTML][HTML] COVID-19 vaccine challenges: What have we learned so far and what remains to be done?
Abstracts Developing and distributing a safe and effective SARS-CoV-2 (COVID-19) vaccine
has garnered immense global interest. Less than a year after COVID-19 was declared a …
has garnered immense global interest. Less than a year after COVID-19 was declared a …
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment
The COVID-19 pandemic is unlikely to end until there is global roll-out of vaccines that
protect against severe disease and preferably drive herd immunity. Regulators in numerous …
protect against severe disease and preferably drive herd immunity. Regulators in numerous …
[HTML][HTML] The race to a COVID-19 vaccine: Opportunities and challenges in development and distribution
RM Burgos, ME Badowski, E Drwiega… - Drugs in …, 2021 - ncbi.nlm.nih.gov
The unprecedented toll of severe acute respiratory syndrome coronavirus 2, the virus
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …
responsible for coronavirus 2019 disease (COVID-19), jumpstarted the race towards the …
Clinical development and approval of COVID-19 vaccines
U Kalinke, DH Barouch, R Rizzi… - Expert Review of …, 2022 - Taylor & Francis
ABSTRACT Introduction The coronavirus 19 (COVID-19) pandemic triggered a
simultaneous global demand for preventative vaccines, which quickly became a high priority …
simultaneous global demand for preventative vaccines, which quickly became a high priority …
Unwavering regulatory safeguards for COVID-19 vaccines
A Shah, PW Marks, SM Hahn - Jama, 2020 - jamanetwork.com
The coronavirus disease 2019 (COVID-19) pandemic has disrupted normal life and had
significant consequences for human health, with more than 4.6 million cases and more than …
significant consequences for human health, with more than 4.6 million cases and more than …
Landscape and progress of global COVID-19 vaccine development
HY Huang, SH Wang, Y Tang, W Sheng… - Human Vaccines & …, 2021 - Taylor & Francis
The emergence of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has
affected billions of lives globally, and the world hopes to end this epidemic by effective …
affected billions of lives globally, and the world hopes to end this epidemic by effective …
COVID-19 Vaccine To Vaccination: Why Leaders Must Invest In Delivery Strategies Now: Analysis describe lessons learned from past pandemics and vaccine …
RL Weintraub, L Subramanian, A Karlage, I Ahmad… - Health …, 2021 - healthaffairs.org
Worldwide, leaders are implementing nonpharmaceutical interventions to slow transmission
of the novel coronavirus while pursuing vaccines that confer immunity to severe acute …
of the novel coronavirus while pursuing vaccines that confer immunity to severe acute …
Addressing vaccine inequity—Covid-19 vaccines as a global public good
Covid-19 Vaccines—A Global Public Good The editors of the Journal note that although the
rapid development of Covid-19 vaccines would appear to be a landmark success in global …
rapid development of Covid-19 vaccines would appear to be a landmark success in global …
[HTML][HTML] Logistical challenges for potential SARS-CoV-2 vaccine and a call to research institutions, developers and manufacturers
UH Kartoglu, KL Moore, JS Lloyd - Vaccine, 2020 - ncbi.nlm.nih.gov
In the absence of specific treatment or an effective vaccine, the SARS-CoV epidemic was
brought to an end through public health tools like isolation, quarantine, physical distancing …
brought to an end through public health tools like isolation, quarantine, physical distancing …
COVID-19 vaccination in developing nations: challenges and opportunities for innovation
Vaccines offer a hope toward ending the global pandemic caused by SARS-CoV2. Mass
vaccination of the global population offers hope to curb the spread. Developing nations …
vaccination of the global population offers hope to curb the spread. Developing nations …